Expression of Platelet-Activating Factor Receptor: A Novel Prognosticator in Patients with Hepatocellular Carcinoma following Hepatectomy

Backgrounds and Aims: Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a phospholipid mediator and acts by binding to a specific G-protein-coupled receptor. Though various functions of PAF have been associated with tumor activities, the mechanism of PAF-PAF receptor signaling in the development of hepatocellular carcinoma (HCC) remains to be elucidated. Methods: In this study, PAF receptor (PAFR) expression was examined in hepatoma cell lines (Huh7, PLC/PRF/5 and HepG2) and clinical samples of HCC (n = 60) using immunohistochemical staining. The relationships between the expression of PAFR and clinicopathological parameters were also investigated. Results: An immunohistochemical study showed that 24 HCC cases (40%) showed a lower PAFR expression than non-cancerous hepatocytes. The patients were divided into two groups according to the degree of PAFR expression: the high (n = 36) and low PAFR groups (n = 24). Lower expression of PAFR was correlated with poor differentiation, portal vein invasion, high levels of serum α-fetoprotein and poor prognosis after surgery. In the low PAFR group, multiple recurrences and distant metastases were more often observed than in the high PAFR group. Multivariate analysis revealed that lower PAFR expression in addition to portal vein invasion is significantly related to survival after hepatectomy. Conclusions: A lower expression of PAFR correlated with poor differentiation and a poor prognosis, and may therefore be used as a prognostic marker in HCC after hepatectomy.

[1]  F. Caire,et al.  Platelet‐activating factor and human meningiomas , 2006, Neuropathology and applied neurobiology.

[2]  F. Labrousse,et al.  Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. , 2006, World journal of gastroenterology.

[3]  D. Lev,et al.  Platelet-activating Factor Mediates MMP-2 Expression and Activation via Phosphorylation of cAMP-response Element-binding Protein and Contributes to Melanoma Metastasis* , 2006, Journal of Biological Chemistry.

[4]  S. Theocharis,et al.  Effect of platelet‐activating factor (PAF) receptor antagonist (BN52021) on acetaminophen‐induced acute liver injury and regeneration in rats , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[5]  G. Camussi,et al.  Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. , 2005, The American journal of pathology.

[6]  Yu-Ying Chao,et al.  Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells. , 2004, Cellular signalling.

[7]  S. A. Harvey,et al.  Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis , 2004, Gut.

[8]  F. Sigaux,et al.  Glycoprotein 170 Induces Platelet-Activating Factor Receptor Membrane Expression and Confers Tumor Cell Hypersensitivity to NK-Dependent Cell Lysis1 , 2004, The Journal of Immunology.

[9]  N. Bazan,et al.  Activation of Platelet-activating Factor Receptor-coupled Gαq Leads to Stimulation of Src and Focal Adhesion Kinase via Two Separate Pathways in Human Umbilical Vein Endothelial Cells* , 2004, Journal of Biological Chemistry.

[10]  J. Stankova,et al.  Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor* , 2003, Journal of Biological Chemistry.

[11]  C. Gandhi,et al.  Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. , 2003, Journal of hepatology.

[12]  S. Chakrabarty,et al.  Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells , 2003, Oncogene.

[13]  G. Camussi,et al.  Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet‐activating factor synthesis , 2002, International journal of cancer.

[14]  G. Koh,et al.  Nuclear Factor κB Dependency of Platelet-activating Factor-induced Angiogenesis , 2002 .

[15]  M. Mareel,et al.  Suppression of Cellular Invasion by Activated G-Protein Subunits Gαo, Gαi1, Gαi2, and Gαi3 and Sequestration of Gβγ , 2001 .

[16]  Y. Denizot,et al.  Is there a role of platelet-activating factor in human lung cancer? , 2001, Lung cancer.

[17]  S Russo,et al.  PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. , 2000, The American journal of pathology.

[18]  F. Sigaux,et al.  Interferon-γ–induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis , 2000 .

[19]  T. Okamoto,et al.  Participation of platelet‐activating factor in the lipopolysaccharide‐induced liver injury in partially hepatectomized rats , 1999, Hepatology.

[20]  M. Kagnoff,et al.  Human intestinal epithelial cells express receptors for platelet-activating factor. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[21]  A. Sapino,et al.  Potential angiogenic role of platelet-activating factor in human breast cancer. , 1998, The American journal of pathology.

[22]  M. Mareel,et al.  Inhibition by Platelet-activating Factor of Src- and Hepatocyte Growth Factor-dependent Invasiveness of Intestinal and Kidney Epithelial Cells , 1998, The Journal of Biological Chemistry.

[23]  S. Sato,et al.  In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. , 1998, The Journal of investigative dermatology.

[24]  T. Shanley,et al.  Role of Kupffer cells in gut ischemia/reperfusion‐induced hepatic microvascular dysfunction in mice , 1997, Hepatology.

[25]  Takao Shimizu,et al.  Platelet-activating Factor (PAF) Induces Growth Stimulation, Inhibition, and Suppression of Oncogenic Transformation in NRK Cells Overexpressing the PAF Receptor* , 1997, The Journal of Biological Chemistry.

[26]  S. Hirohashi,et al.  Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver. , 1997, Journal of hepatology.

[27]  D. Remick,et al.  Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. , 1997, The Biochemical journal.

[28]  S. Im,et al.  Augmentation of tumor metastasis by platelet-activating factor. , 1996, Cancer research.

[29]  S. Nakamura,et al.  Involvement of platelet‐activating factor in cytokine production and neutrophil activation after hepatic ischemia‐reperfusion , 1996, Hepatology.

[30]  Takao Shimizu,et al.  Platelet-activating factor receptor: gene expression and signal transduction. , 1995, Biochimica et biophysica acta.

[31]  G. Camussi,et al.  Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.

[32]  E. Nishida,et al.  Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[33]  M. Olson,et al.  Inflammation and platelet‐activating factor production during hepatic ischemia/reperfusion , 1992, Hepatology.

[34]  D. Hanahan,et al.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.

[35]  C. Gandhi,et al.  89 Kupffer cells are a major source of increased platelet activating factor in the CCL-induced cirrhotic rat liver , 2003 .

[36]  S. Ishii,et al.  Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. , 2000, Progress in lipid research.

[37]  J. Miyazaki,et al.  Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor , 1997, The EMBO journal.